Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-21-000131
Filing Date
2021-09-15
Accepted
2021-09-15 16:01:35
Documents
1
Period of Report
2021-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163173607782364.html 4  
1 FORM 4 wf-form4_163173607782364.xml 4 7167
  Complete submission text file 0001385508-21-000131.txt   8872
Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address 919-678-6611
Collard Craig A (Reporting) CIK: 0001363558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 211255430

Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations